BFB759

· Bluefin Biomedicine, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BFB759, covering 2026-04-03 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis [Phase 2]